Urokinase-type Plasminogen Activator Receptor Signaling is Critical in Nasopharyngeal Carcinoma Cell Growth and Metastasis.
Ying-Na Bao,Xue Cao,Dong-Hua Luo,Rui Sun,Li-Xia Peng,Lin Wang,Yong-Pan Yan,Li-Sheng Zheng,Ping Xie,Yun Cao,Ying-Ying Liang,Fang-Jing Zheng,Bi-Jun Huang,Yan-Qun Xiang,Xing Lv,Qiu-Yan Chen,Ming-Yuan Chen,Pei-Yu Huang,Ling Guo,Hai-Qiang Mai,Xiang Guo,Yi-Xin Zeng,Chao-Nan Qian
DOI: https://doi.org/10.4161/cc.28921
2014-01-01
Abstract:Nasopharyngeal carcinoma (NPC) is one of the most common malignancies in southern China and Southeast Asia, with the highest metastasis rate among head and neck cancers. The mechanisms underlying NPC progression remain poorly understood. Genome-wide expression profiling on 18 NPC vs. 18 noncancerous nasopharyngeal tissues together with GeneGo pathway analysis and expression verification in NPC cells and tissues revealed a potential role of urokinase-type plasminogen activator receptor (uPAR) in NPC progression, which has not been investigated in NPC. We then observed that uPAR expression is increased in poorly differentiated, highly metastatic NPC cells compared with lowly metastatic cells or differentiated NPC cells. In vitro studies demonstrated that uPAR regulates NPC cell growth, colony formation, migration, and invasion and promotes the epithelial-mesenchymal transition (EMT). Additional tumor xenograft and spontaneous metastasis experiments revealed that uPAR promotes NPC cell growth and metastasis in vivo. The JAK-STAT pathway is involved in uPAR-regulated signaling in NPC cells as determined by immunoblotting. Moreover, uPAR-mediated growth and motility is partially abolished upon treatment with the Jak1/Jak2 inhibitor INCB018424. We suppressed uPA expression in uPAR-overexpressing NPC cells and found that uPAR-mediated cellular growth and motility is not exclusively dependent on uPA. In summary, uPAR is a significant regulator of NPC progression and could serve as a promising therapeutic target.